NPCE stock · UBER stock

NPCE vs UBER · rev $79.9M vs P/E 18, rev $52.02B

Neuropace Inc (NPCE) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.

Neuropace Inc (NPCE) is a medical devices company listed on US.

Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.

Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.

Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.

NPCE currently screens at market cap $312.2M. UBER currently screens at market cap $144.34B and trailing P/E 17.6.

Not investment advice. Open the NPCE and UBER stock pages for the full models.

Not investment advice.

Popular Stock Comparisons